Stock vs Stock Comparison

Stryker Corporation vs Johnson & Johnson

JNJ wins the Tale of the Tape 5–3.

SYK$295.00
JNJ$223.24

🏆 Tale of the Tape

35
SYKJNJ
12.9%Profitability (Net Margin)28.5%
35.4xValuation (P/E)26.1x
10.1%Efficiency (ROIC)18.3%
4/9Health (Piotroski F)4/9
4.7Safety (Altman Z)4.0
11.2%Growth (Rev YoY)6.0%
-0.33Risk (Sharpe 1Y)2.69
1.13xBalance Sheet (D/E)1.44x
3.04%FCF Yield3.25%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.224
252-Day Correlation
0.189
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricSYKJNJ
Market Cap$117.0B$542.4B
P/E Ratio35.4x26.1x
Forward P/E18.2x17.7x
P/B5.21x6.68x
Dividend Yield1.15%2.38%
Beta0.810.26

Quantitative Metrics

MetricSYKJNJ
DCF Fair Value$374.97$134.24
DCF Upside+8.0%-43.6%
Piotroski F4/94/9
Altman Z4.723.97
Beneish M-2.62-2.27
FCF Yield3.04%3.25%
Net Debt/EBITDA1.7x0.5x
ROIC10.1%18.3%
WACC9.9%7.7%
ROIC – WACC0.2pp10.5pp
Gross Margin64.0%67.9%
Net Margin12.9%28.5%
Rev Growth YoY11.2%6.0%
Sharpe (1Y)-0.332.69
Max Drawdown 3Y-16.0%
FCF Payout Ratio30%64%

SYK Price

Loading chart...

JNJ Price

Loading chart...

ETF Exposure

SYK found in:

IHI11.04%
XLV2.02%
VHT1.76%
XHE1.55%
MGV0.54%
VIG0.49%
DGRW0.45%
SCHV0.45%
VUG0.33%
IWD0.28%
VONV0.25%
ESGV0.23%
SPYV0.22%
SPLG0.22%
SCHX0.21%
IVV0.21%
RSP0.20%
SCHB0.20%
ITOT0.18%
VOO0.18%
VONE0.17%
SPY0.17%
VTI0.16%
SPTM0.16%
URTH0.16%
ACWI0.13%
SPYG0.13%
IWF0.10%
VT0.10%
VONG0.09%
QUS0.04%
ONEO0.03%

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

SYK vs JNJ: Head-to-Head Analysis

Stryker Corporation (SYK) and Johnson & Johnson (JNJ) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, JNJ leads 5–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, SYK generates a return on invested capital (ROIC) of 10.1% compared to JNJ's 18.3%. This suggests JNJ is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between SYK and JNJ is 0.224, indicating low correlation, making them an effective diversification pair in a portfolio context.

SYK appears in 32 ETFs tracked by SecuritiesDB, while JNJ appears in 39 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, SYK or JNJ?

Our quantitative analysis compares SYK and JNJ across nine fundamental dimensions. JNJ wins the Tale of the Tape 5–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are SYK and JNJ correlated?

The 252-day correlation between SYK and JNJ is 0.224. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.